Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Broad immune components is a non-specific term encompassing the entire collective of cells, tissues, and molecules that facilitate the body's defense against pathogens and internal aberrations. This category includes the innate immune system (e.g., neutrophils, macrophages, complement proteins) and the adaptive immune system (e.g., B-cells, T-cells, antibodies). Because it represents a complex biological system rather than a single protein or pathway, it is not classified as a discrete therapeutic target. In clinical practice and drug development, pharmacological agents are designed to modulate specific elements within this broad system, such as individual cytokines or cell-surface receptors, to treat autoimmune diseases, prevent organ transplant rejection, or enhance anti-tumor immunity. Consequently, the term is considered too broad for precise target identification in drug discovery databases.
Various mechanisms including broad immunosuppression, cytokine inhibition, T-cell modulation, and immune checkpoint blockade.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Broad immune components.